Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.44 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.43 |
| ▸ | ADH1B | P00325 | 1/20 | 0.43 |
| ▸ | ADH1C | P00326 | 1/20 | 0.43 |
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | ADH4 | P08319 | 1/20 | 0.43 |
| ▸ | ADH7 | P40394 | 1/20 | 0.43 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.42 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4451574 | 1.00 | FDPS (0.46) | FDPSMAPTOPRM1GPR84ADH1B | |
| SCHEMBL18985093 | 1.00 | FDPS (0.46) | FDPSMAPTOPRM1GPR84ADH1B | |
| SCHEMBL4699570 | 1.00 | FDPS (0.46) | FDPSMAPTOPRM1GPR84ADH1B | |
| SCHEMBL276114 | 1.00 | FDPS (0.46) | FDPSMAPTOPRM1GPR84ADH1B | |
| SCHEMBL2670965 | 1.00 | FDPS (0.46) | FDPSMAPTOPRM1GPR84ADH1B | |
| SCHEMBL1831666 | 1.00 | FDPS (0.46) | FDPSMAPTOPRM1GPR84ADH1B | |
| SCHEMBL14732171 | 1.00 | FDPS (0.46) | FDPSMAPTOPRM1GPR84ADH1B | |
| SCHEMBL7263751 | 1.00 | FDPS (0.46) | FDPSMAPTOPRM1GPR84ADH1B | |
| SCHEMBL7259802 | 1.00 | FDPS (0.46) | FDPSMAPTOPRM1GPR84ADH1B | |
| SCHEMBL3307877 | 1.00 | FDPS (0.46) | FDPSMAPTOPRM1GPR84ADH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0559625-B1 | Esters of L-carnitine and acyl L-carnitine endowed with muscle relaxant activityselective on gastrointestinal tract and pharmaceutical compositions containing same | SIGMA TAU IND FARMACEUTI (IT) | 1997-08-27 | — | — | EP | claimed |
| EP-0634392-B1 | Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock | SIGMA TAU IND FARMACEUTI (IT) | 1997-02-05 | — | — | EP | claimed |
| EP-0559625-A2 | Esters of L-carnitine and acyl L-carnitine endowed with muscle relaxant activityselective on gastrointestinal tract and pharmaceutical compositions containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1993-09-08 | — | — | EP | claimed |
| EP-0337731-A2 | Peptide antibiotics | ELI LILLY AND COMPANY (US) | 1989-10-18 | — | — | EP | claimed |
| CN-111848778-B | Teriparatide analogues | 上海医药工业研究院 | 2024-03-19 | — | — | CN | disclosed |
| CN-114106091-A | Protein analogs and conjugates thereof | 正大天晴药业集团股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| CN-111247162-B | Polymyxin analogs and preparation method thereof | 正大天晴药业集团股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
| CN-112566675-A | Freshening compositions comprising controlled release modulators | 阿里莱森斯有限公司 | 2021-03-26 | — | — | CN | disclosed |
| CN-111848778-A | Teriparatide analogues | 上海医药工业研究院 | 2020-10-30 | — | — | CN | disclosed |
| CN-111247162-A | Polymyxin analogs and preparation method thereof | 正大天晴药业集团股份有限公司 | 2020-06-05 | — | — | CN | disclosed |
| EP-2439204-B1 | HETEROCYCLIC COMPOUND AND HEMATOPOIETIC STEM CELL AMPLIFIER | NISSAN CHEMICAL IND LTD (JP) | 2017-01-04 | — | — | EP | disclosed |
| US-9527828-B2 | Method for expanding hematopoietic stem cells using heterocyclic compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-12-27 | — | — | US | disclosed |
| EP-0536936-B1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | SANKYO CO (JP) | 1996-08-14 | — | — | EP | disclosed |
| US-5391564-A | E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents | SANKYO COMPANY, LIMITED (JP) | 1995-02-21 | — | — | US | disclosed |
| US-5352689-A | Rhizoxin derivatives and their use as anti-tumor agents | SANKYO COMPANY, LIMITED (JP) | 1994-10-04 | — | — | US | disclosed |
| EP-0583971-A1 | Piperidine derivatives | SANKYO COMPANY LIMITED (JP) | 1994-02-23 | — | — | EP | disclosed |
| EP-0559625-A2 | Esters of L-carnitine and acyl L-carnitine endowed with muscle relaxant activityselective on gastrointestinal tract and pharmaceutical compositions containing same | Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) | 1993-09-08 | — | — | EP | disclosed |
| EP-0350315-B1 | RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS | SANKYO COMPANY LIMITED (JP) | 1993-06-16 | — | — | EP | disclosed |
| EP-0536936-A1 | Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use | Sankyo Company Limited (JP) | 1993-04-14 | — | — | EP | disclosed |
| EP-0350315-A1 | Rhizoxin derivates and their use as anti-tumor agents | SANKYO COMPANY LIMITED (JP) | 1990-01-10 | — | — | EP | disclosed |